Hvsen Biotech
30087120.721.47% ( +0.30 )
Hvsen Biotech (300871)
Wuhan Hvsen Biotechnology Co.,Ltd. is involved in the research and development, and manufacture of macrolides APIs and preparations in China and internationally...
- Open
- 20.42
- High
- 20.90
- Low
- 20.31
- Prev. Close
- 20.42
- Volume
- 45.84K
- Turnover
- 94.93M
- Avg Price
- 20.71
- Bid/Ask Ratio
- 9.80%
- Amplitude
- 2.89%
- 52wk High
- 32.42
- Volume Ratio
- 0.52
- Turnover Ratio
- 2.27%
Hvsen Biotech Analyst Rating
View MoreForecast & Rating
Dec 1, 2025Price forecast
¥28.0535.38%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- 36Kr · Feb 5 at 05:58 AM
Hvsen Biotech: Invests 1 billion yuan to build a synthetic biology manufacturing project in Xinjiang
- Zhitong · Oct 27, 2025 at 06:45 AM
Hvsen Biotech released its performance for the first three quarters, with a net profit attributable to the parent company of 188 million yuan, an increase of 494.28%
- Zhitong · Sep 30, 2025 at 02:55 AM
Hvsen Biotech: Subsidiary "Yinqiao Lanjin Oral Solution" Obtains New Veterinary Drug Registration Certificate
- Zhitong · Aug 11, 2025 at 08:27 PM
Hvsen Biotech: In the first half of this year, it has obtained 7 pet product approvals, greatly expanding its pet product line
- Zhitong · Aug 5, 2025 at 05:49 AM
Hvsen Biotech plans to invest CNY 170 million to implement a green equipment technological transformation project for veterinary raw materials
- Zhitong · Aug 5, 2025 at 05:45 AM
Hvsen Biotech released its performance for the first half of the year, turning a loss into a profit of 117 million yuan
